Nadine Anaizi, PA-C

Nadine Anaizi practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Nadine Anaizi's NPI, 1164752515, was assigned on January 7, 2010. Nadine Anaizi holds California license 56459.

Nadine Anaizi's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Nadine Anaizi's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Nadine Anaizi to 1 more hospital and 2 medical groups, each named with a free account. Nadine Anaizi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Nadine Anaizi practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Nadine Anaizi's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Nadine Anaizi is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Nadine Anaizi's licenses on file in 2 states: California and New York.

CMS data shows 120 Medicare services from Nadine Anaizi across 2 procedure codes in 2024, all of them office visits, for 75 Medicare patients. Medicare paid $15,005 for them. Every service was in an office.

CMS counts 75 Medicare patients who saw Nadine Anaizi in 2024. The largest group is 65 to 74, with 32 patients. 71% of them have high cholesterol, and 63% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nadine Anaizi's median patient age at 42, with 51% women.

In 2024, Nadine Anaizi wrote 114 Medicare Part D claims for 38 patients. 61% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $11,319 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Nadine Anaizi for performance year 2024, reported as part of a group. Nadine Anaizi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nadine Anaizi as offering telehealth.